7.6 C
New York
Sunday, April 2, 2023

The Question Is Whether To Buy Or Not To Buy Avid Bioservices Inc. (NASDAQ: CDMO)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Avid Bioservices Inc. (CDMO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.14, or 1.00%, to $14.09. The Avid Bioservices Inc. has recorded 32,753 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Stocks Info

Avid Bioservices Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $13.95 and fluctuated between $14.95 as its day high and $13.48 as its day low. The current market capitalization of Avid Bioservices Inc. is $923.35M. A total of 1.4 million shares were traded on the day, compared to an average of 513.45K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CDMO has seen 18 BUY and 8 SELL insider trades, representing the acquisition of 57,835 and the disposition of 26,070 shares. Over the last 12 months, there were 58 BUYs and 34 SELLs from insiders. Insiders purchased 277,166 shares during that period but sold 141,803.

In the most recent transaction, Hancock Richard B sold 5,000 shares of CDMO for 16.59 per share on Mar 01. After the transaction, the Director now owns 39,134 company shares. In a previous transaction on Feb 01, Hancock Richard B sold 5,000 shares at 16.02 per share. CDMO shares that Director owns now total 39,134.

Among the insiders who sold shares, Alegria Esther M. disposed of 5,321 shares on Jan 13 at a per-share price of $16.32. This resulted in the Director holding 0 shares of CDMO after the transaction. In another insider transaction, Hancock Richard B sold 5,000 shares at $16.00 per share on Jan 12. Company shares held by the Director now total 39,134.


It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. CDMO’s most recent ex-dividend date was 3/16/2018 when it declared a $0.6563 quarterly dividend that was paid in cash on 4/2/2018.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CDMO in the last 3 months, the mean price target is $22.33 with high estimates of $25.00 and low estimates of $20.00. In terms of 52-week highs and lows, CDMO has a high of $22.38 and a low of $11.30.

As of this writing, CDMO has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.04. The company reported an EPS of $0.02 in the last quarter, which was -50.00% lower than expectations of $0.04.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDMO is Buy with a score of 4.00. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles